AKT1 and pneumonia: Bioinformatics analysis of the 120 bioactive ingredients of XBS and the 128 corresponding pneumonia-related targets revealed that these ingredients are involved in the regulation of inflammation-related pathways (the IL-17 signaling pathway, TNF signaling pathway, PI3K/Akt signaling pathway and MAPK signaling pathway).